Company
Xeris Biopharma Holdings, Inc.
XERS · CIK 0001867096
Sale of 16,666 shares at $8.4864 per share.
Reporting Person Hecht Beth · Officer Title See Remarks · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001652410-26-000018 · filed 2026-09-01 · View filing →
Sale of 5,000 shares at $8.50 per share.
Reporting Person Pieper Steven · Officer Title See Remarks · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001875714-26-000012 · filed 2026-09-01 · View filing →
Sale of 15,000 shares at $8.4872 per share.
Reporting Person McCulloch Kevin · Officer Title See Remarks · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0002031695-26-000011 · filed 2026-09-01 · View filing →
Disposition (code F) of 21,918 shares at $8.08 per share.
Reporting Person McCulloch Kevin · Officer Title See Remarks · Transaction Code F
Traded Aug 1, 2026 · Disclosed Aug 21, 2026FILED +20 DAYS
Source: SEC Form 4 · 0001867096-26-000069 · filed 2026-08-21 · View filing →
Disposition (code F) of 36,645 shares at $8.08 per share.
Reporting Person Shannon John Patrick Jr · Officer Title See Remarks · Transaction Code F
Traded Aug 1, 2026 · Disclosed Aug 21, 2026FILED +20 DAYS
Source: SEC Form 4 · 0001867096-26-000073 · filed 2026-08-21 · View filing →
Sale of 5,000 shares at $8.50 per share.
Reporting Person Pieper Steven · Officer Title See Remarks · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001875714-26-000009 · filed 2026-08-12 · View filing →